DEA KRATOM BAN- Is Kratom Illegal?

Historically, the FDA has maintained a firm stance that raw botanical kratom is an unapproved new dietary ingredient and an unsafe food additive, warning consumers against its use due to safety and dependency concerns. In the absence of a blanket federal ban under the Controlled Substances Act, individual states took matters into their own hands. A handful of states—including Alabama, Indiana, and most recently Connecticut and Tennessee—enacted total prohibitions on all kratom materials. Meanwhile, more than thirty states adopted the Kratom Consumer Protection Act (KCPA) framework, choosing to keep the natural leaf legal for adults while enforcing age restrictions, strict heavy-metal testing, and labeling standards. (1)

The newest, most significant development focuses directly on the commercial explosion of highly concentrated extracts and semi-synthetic isolates. The DEA filed an official Notice of Intent to temporarily place 7-hydroxymitragynine (7-OH)—one of kratom’s primary, highly potent alkaloids—into Schedule I of the Controlled Substances Act, alongside substances like heroin and LSD. Backed by scientific evaluations from the FDA and HHS, federal regulators are targeting what they term "deceptive" commercial products (such as pressed 7-OH tablets, shots, and isolates) that present an imminent hazard to public safety due to their elevated, often chemically altered potency. (2)

To put this simply, the ban only targets the higher potency extracts like 7-hydroxymitragine but also extracts targeting the following alkaloids: 

• Mitragynine pseudoindoxyl (MP)
• Dihydro-7-hydroxymitragynine (MGM-15)
• The 9-fluoro derivative of 7-hydroxymitragynine (MGM-16)

Crucially for the broader botanical community, the DEA and HHS have explicitly clarified that this enforcement hammer is not designed to criminalize or eliminate natural, whole-leaf botanical kratom (Mitragyna speciosa). Because raw plant powders, traditional teas, and standard full-spectrum leaf products naturally contain only minor trace elements of 7-OH well below the federal threshold, they remain unscheduled and legally accessible in states protected by the Kratom Consumer Protection Act (KCPA). For ethical vendor operations and retail brands, the path forward requires an aggressive pivot toward transparency, absolute elimination of synthetic isolates, and mandatory third-party laboratory panel testing to rigorously document natural-spectrum alkaloid ratios before products ever hit the shelves. (3) (4)

(1) Kratom 101: What You Need to Know | ASTHO

(2) (4) DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety
 (3) - HHS, FDA Commend DEA Action Against Dangerous Enhanced 7-OH Products | HHS.gov